Developing and Using Therapeutics for Emerging Infections
Identifieur interne : 001993 ( Main/Exploration ); précédent : 001992; suivant : 001994Developing and Using Therapeutics for Emerging Infections
Auteurs : Jeannine S. Mccune [États-Unis] ; Kellie S. Reynolds [États-Unis]Source :
- Clinical Pharmacology & Therapeutics [ 0009-9236 ] ; 2015-10.
Abstract
This issue of Clinical Pharmacology & Therapeutics focuses on emerging infections. The outbreaks of the vaccine‐preventable diseases (e.g., measles) and the emerging pathogens (e.g., Ebola) show us how small the world has become. These outbreaks also show the pressing need for effective public education and development of novel therapies. This issue covers various aspects of relevant therapeutic topics ranging from preclinical models, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial results, to education efforts in this area. Pharmacokinetic/dynamic modeling had an appreciable role in reducing the morbidity and mortality associated with human immunodeficiency virus and hepatitis C virus, recent emerging infections. However, these gains could be lessened by poor adherence to therapies, which has contributed to the development of multidrug‐resistant tuberculosis. We must not forget lessons from previous infections, or they may reemerge.
Url:
DOI: 10.1002/cpt.183
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000151
- to stream Istex, to step Curation: 000151
- to stream Istex, to step Checkpoint: 000137
- to stream Main, to step Merge: 001998
- to stream Main, to step Curation: 001993
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Developing and Using Therapeutics for Emerging Infections</title><author><name sortKey="Mccune, Jeannine S" sort="Mccune, Jeannine S" uniqKey="Mccune J" first="Jeannine S." last="Mccune">Jeannine S. Mccune</name></author><author><name sortKey="Reynolds, Kellie S" sort="Reynolds, Kellie S" uniqKey="Reynolds K" first="Kellie S." last="Reynolds">Kellie S. Reynolds</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:06DBCF2DBEFEBB9445EA2CD450FEC12E9BE024E4</idno><date when="2015" year="2015">2015</date><idno type="doi">10.1002/cpt.183</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-ZJS4G057-8/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000151</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000151</idno><idno type="wicri:Area/Istex/Curation">000151</idno><idno type="wicri:Area/Istex/Checkpoint">000137</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000137</idno><idno type="wicri:doubleKey">0009-9236:2015:Mccune J:developing:and:using</idno><idno type="wicri:Area/Main/Merge">001998</idno><idno type="wicri:Area/Main/Curation">001993</idno><idno type="wicri:Area/Main/Exploration">001993</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Developing and Using Therapeutics for Emerging Infections</title><author><name sortKey="Mccune, Jeannine S" sort="Mccune, Jeannine S" uniqKey="Mccune J" first="Jeannine S." last="Mccune">Jeannine S. Mccune</name><affiliation wicri:level="4"><orgName type="university">Université de Washington</orgName><country>États-Unis</country><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Reynolds, Kellie S" sort="Reynolds, Kellie S" uniqKey="Reynolds K" first="Kellie S." last="Reynolds">Kellie S. Reynolds</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Maryland, Silver Spring</wicri:regionArea><wicri:noRegion>Silver Spring</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Clinical Pharmacology & Therapeutics</title><title level="j" type="alt">CLINICAL PHARMACOLOGY AND THERAPEUTICS</title><idno type="ISSN">0009-9236</idno><idno type="eISSN">1532-6535</idno><imprint><biblScope unit="vol">98</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="346">346</biblScope><biblScope unit="page" to="351">351</biblScope><biblScope unit="page-count">6</biblScope><date type="published" when="2015-10">2015-10</date></imprint><idno type="ISSN">0009-9236</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0009-9236</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">This issue of Clinical Pharmacology & Therapeutics focuses on emerging infections. The outbreaks of the vaccine‐preventable diseases (e.g., measles) and the emerging pathogens (e.g., Ebola) show us how small the world has become. These outbreaks also show the pressing need for effective public education and development of novel therapies. This issue covers various aspects of relevant therapeutic topics ranging from preclinical models, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial results, to education efforts in this area. Pharmacokinetic/dynamic modeling had an appreciable role in reducing the morbidity and mortality associated with human immunodeficiency virus and hepatitis C virus, recent emerging infections. However, these gains could be lessened by poor adherence to therapies, which has contributed to the development of multidrug‐resistant tuberculosis. We must not forget lessons from previous infections, or they may reemerge.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Washington (État)</li></region><settlement><li>Seattle</li></settlement><orgName><li>Université de Washington</li></orgName></list><tree><country name="États-Unis"><region name="Washington (État)"><name sortKey="Mccune, Jeannine S" sort="Mccune, Jeannine S" uniqKey="Mccune J" first="Jeannine S." last="Mccune">Jeannine S. Mccune</name></region><name sortKey="Mccune, Jeannine S" sort="Mccune, Jeannine S" uniqKey="Mccune J" first="Jeannine S." last="Mccune">Jeannine S. Mccune</name><name sortKey="Reynolds, Kellie S" sort="Reynolds, Kellie S" uniqKey="Reynolds K" first="Kellie S." last="Reynolds">Kellie S. Reynolds</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001993 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001993 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:06DBCF2DBEFEBB9445EA2CD450FEC12E9BE024E4
|texte= Developing and Using Therapeutics for Emerging Infections
}}
| This area was generated with Dilib version V0.6.33. |  |